Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Delfi Diagnostics Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Weill Medical College of Cornell University
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Daiichi Sankyo
H. Lee Moffitt Cancer Center and Research Institute
Daiichi Sankyo
Jiangsu HengRui Medicine Co., Ltd.
AVEO Pharmaceuticals, Inc.